467 related articles for article (PubMed ID: 28810146)
21. RNA profiling of blood platelets noninvasively differentiates colorectal cancer from healthy donors and noncancerous intestinal diseases: a retrospective cohort study.
Xu L; Li X; Li X; Wang X; Ma Q; She D; Lu X; Zhang J; Yang Q; Lei S; Wang L; Wang Z
Genome Med; 2022 Mar; 14(1):26. PubMed ID: 35236405
[TBL] [Abstract][Full Text] [Related]
22. Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer.
Nilsson RJ; Karachaliou N; Berenguer J; Gimenez-Capitan A; Schellen P; Teixido C; Tannous J; Kuiper JL; Drees E; Grabowska M; van Keulen M; Heideman DA; Thunnissen E; Dingemans AM; Viteri S; Tannous BA; Drozdowskyj A; Rosell R; Smit EF; Wurdinger T
Oncotarget; 2016 Jan; 7(1):1066-75. PubMed ID: 26544515
[TBL] [Abstract][Full Text] [Related]
23. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
24. Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.
Yao Y; Liu J; Li L; Yuan Y; Nan K; Wu X; Zhang Z; Wu Y; Li X; Zhu J; Meng X; Wei L; Chen J; Jiang Z
Oncotarget; 2017 Jan; 8(2):2130-2140. PubMed ID: 27791985
[TBL] [Abstract][Full Text] [Related]
25. Tumor-Educated Platelets as a Promising Biomarker for Blood-Based Detection of Renal Cell Carcinoma.
Xiao R; Liu C; Zhang B; Ma L
Front Oncol; 2022; 12():844520. PubMed ID: 35321426
[TBL] [Abstract][Full Text] [Related]
26. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
[TBL] [Abstract][Full Text] [Related]
27. Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer.
Muller M; Best MG; van der Noort V; Hiltermann TJN; Niemeijer AN; Post E; Sol N; In 't Veld SGJG; Nogarede T; Visser L; Schouten RD; van den Broek D; Hummelink K; Monkhorst K; de Langen AJ; Schuuring E; Smit EF; Groen HJM; Wurdinger T; van den Heuvel MM
Tumour Biol; 2024; 46(s1):S327-S340. PubMed ID: 37270827
[TBL] [Abstract][Full Text] [Related]
28. TEP RNA: a new frontier for early diagnosis of NSCLC.
Wang Y; Dong A; Jin M; Li S; Duan Y
J Cancer Res Clin Oncol; 2024 Feb; 150(2):97. PubMed ID: 38372784
[TBL] [Abstract][Full Text] [Related]
29. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
30. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
[TBL] [Abstract][Full Text] [Related]
31. Tumour-educated platelets for breast cancer detection: biological and technical insights.
Liefaard MC; Moore KS; Mulder L; van den Broek D; Wesseling J; Sonke GS; Wessels LFA; Rookus M; Lips EH
Br J Cancer; 2023 Apr; 128(8):1572-1581. PubMed ID: 36765174
[TBL] [Abstract][Full Text] [Related]
32. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
33. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
34. Computer-aided diagnosis of lung cancer: the effect of training data sets on classification accuracy of lung nodules.
Gong J; Liu JY; Sun XW; Zheng B; Nie SD
Phys Med Biol; 2018 Feb; 63(3):035036. PubMed ID: 29311420
[TBL] [Abstract][Full Text] [Related]
35. [Liquid biopsy : A blood sample for early recognition and therapy control in lung cancer patients].
Hekmat K; Bruns C
Chirurg; 2017 Jul; 88(7):621. PubMed ID: 28616676
[No Abstract] [Full Text] [Related]
36. Compact cancer biomarkers discovery using a swarm intelligence feature selection algorithm.
Martinez E; Alvarez MM; Trevino V
Comput Biol Chem; 2010 Aug; 34(4):244-50. PubMed ID: 20888301
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: Background review of the literature.
DeCotiis C; Hu Y; Greenberg AK; Huie M; Tsay JC; Pass H; Goldberg JD; Rom WN
Cancer Biomark; 2016; 16(2):219-33. PubMed ID: 26756613
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer.
Wang DB; Lu XK; Zhang X; Li ZG; Li CX
Tumour Biol; 2016 Jan; 37(1):553-9. PubMed ID: 26232327
[TBL] [Abstract][Full Text] [Related]
39. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
40. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
